[Federal Register Volume 64, Number 77 (Thursday, April 22, 1999)]
[Notices]
[Page 19743]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-10092]


 ========================================================================
 Notices
                                                 Federal Register
 ________________________________________________________________________
 
 This section of the FEDERAL REGISTER contains documents other than rules 
 or proposed rules that are applicable to the public. Notices of hearings 
 and investigations, committee meetings, agency decisions and rulings, 
 delegations of authority, filing of petitions and applications and agency 
 statements of organization and functions are examples of documents 
 appearing in this section.
 
 ========================================================================
 

  Federal Register / Vol. 64, No. 77 / Thursday, April 22, 1999 / 
Notices  

[[Page 19743]]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

Animal and Plant Health Inspection Service
[Docket No. 99-026-1]


Availability of an Environmental Assessment and Finding of No 
Significant Impact for Field Testing Salmonella Dublin Vaccine, Live 
Culture

AGENCY: Animal and Plant Health Inspection Service, USDA.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: We are advising the public that the Animal and Plant Health 
Inspection Service has prepared an environmental assessment and finding 
of no significant impact concerning authorization to ship for the 
purpose of field testing, and then to field test, an unlicensed live 
Salmonella dublin vaccine for use in cattle. A risk analysis, which 
forms the basis for the environmental assessment, has led us to 
conclude that field testing this veterinary vaccine will not have a 
significant impact on the quality of the human environment. Based on 
our finding of no significant impact, we have determined that an 
environmental impact statement need not be prepared. We intend to 
authorize shipment of this vaccine for field testing 14 days after the 
date of this notice, unless new substantial issues bearing on the 
effects of this action are brought to our attention. We also intend to 
issue a veterinary biological product license for this vaccine, 
provided the field test data support the conclusions of the 
environmental assessment and finding of no significant impact and the 
product meets all other requirements for licensure.

ADDRESSES: Copies of the environmental assessment and finding of no 
significant impact may be obtained by contacting the person listed 
under FOR FURTHER INFORMATION CONTACT. Please refer to the docket 
number, date, and complete title of this notice when requesting copies. 
Copies of the environmental assessment and finding of no significant 
impact (as well as the risk assessment with confidential business 
information removed) are available for public inspection at USDA, room 
1141, South Building, 14th Street and Independence Avenue SW., 
Washington, DC, between 8 a.m. and 4:30 p.m., Monday through Friday, 
except holidays. Persons wishing to inspect those documents are 
requested to call ahead on (202) 690-2817 to facilitate entry into the 
reading room.

FOR FURTHER INFORMATION CONTACT: Dr. Jeanette Greenberg, Technical 
Writer-Editor, Center for Veterinary Biologics, Licensing and Policy 
Development, VS, APHIS, USDA, 4700 River Road Unit 148, Riverdale, MD 
20737-1231; telephone (301) 734-5338; fax (301) 734-4314; or e-mail: 
Jeanette.B.G[email protected].

SUPPLEMENTARY INFORMATION: Under the Virus-Serum-Toxin Act (21 U.S.C. 
151 et seq.), a veterinary biological product must be shown to be pure, 
safe, potent, and efficacious before a veterinary biological product 
license may be issued. A field test is generally necessary to satisfy 
prelicensing requirements for veterinary biological products. Prior to 
conducting a field test on an unlicensed product, an applicant must 
obtain approval from the Animal and Plant Health Inspection Service 
(APHIS), as well as obtain APHIS' authorization to ship the product for 
field testing.
    To determine whether to authorize shipment and grant approval for 
the field testing of the unlicensed product referenced in this notice, 
APHIS conducted a risk analysis to assess the potential effects of this 
product on the safety of animals, public health, and the environment. 
Based on the risk analysis, APHIS has prepared an environmental 
assessment (EA). APHIS has concluded that field testing the unlicensed 
veterinary biological product will not significantly affect the quality 
of the human environment. Based on this finding of no significant 
impact (FONSI), we have determined that there is no need to prepare an 
environmental impact statement.
    An EA and FONSI have been prepared by APHIS concerning the field 
testing of the following unlicensed veterinary biological product:
    Requester: Fort Dodge Laboratories, Inc., Division of American Home 
Products Corporation.
    Product: Salmonella Dublin Vaccine, Live Culture.
    Field test locations: California, Colorado, Indiana, and Wisconsin.
    The above-mentioned vaccine is for use in cattle as an aid in the 
prevention of clinical disease caused by Salmonella dublin. The vaccine 
bacteria contain the aro A deletion, which limits the ability of the 
bacteria to replicate in vertebrate tissues.
    The EA and FONSI have been prepared in accordance with: (1) The 
National Environmental Policy Act of 1969 (NEPA), as amended (42 U.S.C. 
4321 et seq.), (2) regulations of the Council on Environmental Quality 
for implementing the procedural provisions of NEPA (40 CFR parts 1500-
1508), (3) USDA regulations implementing NEPA (7 CFR part 1b), and (4) 
APHIS' NEPA Implementing Procedures (7 CFR part 372).
    Unless substantial environmental issues are raised in response to 
this notice, APHIS intends to authorize shipment of the above product 
for the initiation of field tests 14 days from the date of this notice.
    Because the issues raised by field testing and by issuance of a 
license are identical, APHIS has concluded that the EA and FONSI that 
were generated for field testing would also be applicable to the 
proposed licensing action. Provided that the field test data support 
the conclusions of the original EA and FONSI, APHIS does not intend to 
issue a separate EA to support the issuance of the product license, and 
would determine that an environmental impact statement need not be 
prepared. APHIS intends to issue a veterinary biological product 
license for this vaccine following completion of the field test 
provided no adverse impacts on the human environment are identified and 
provided the product meets all other requirements for licensure.

    Authority: 21 U.S.C. 151-159.

    Done in Washington, DC, this 16th day of April 1999.
Joan M. Arnoldi,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 99-10092 Filed 4-21-99; 8:45 am]
BILLING CODE 3410-34-P